Examination of why global whole-genome sequencing uptake remains below 1% and how interpretation, not cost, limits adoption.
Key Takeaways
- Whole-genome sequencing costs fell from billions to a few hundred dollars but uptake stays under 1%
- Limited public genomic literacy and uncertain actionability reduce consumer demand for sequencing
- AI promises to integrate genomes with biomarkers and wearables to produce usable personalized health advice